• Title/Summary/Keyword: 바이오헬스 산업

Search Result 35, Processing Time 0.026 seconds

u-Healthy 기술 - (3) u-헬스케어 TRM

  • Na, Seung-Gwon
    • The Monthly Diabetes
    • /
    • s.287
    • /
    • pp.52-55
    • /
    • 2013
  • 2008년 보건산업진흥원의 "u-Healthcare R&D 기본계획 수립" 연구보고서에서 u-헬스케어 기술개발을 "u-헬스케어 인프라", "u-헬스케어 임상-바이오-생체정보 융합기술", "u-헬스케어 서비스 모델", "자유공모" 등 4개의 사업으로 구성하여 추진할 것을 제안했다. u-헬스케어 인프라는 다양한 형태의 u-헬스케어 기술 및 서비스 지원을 위한 인프라 기술 개발, 전문 인력 양성 및 법 제도 정비 등의 내용을 포함하고, u-헬스케어 임상-바이오-생체정보 융합기술은 임상-바이오-생체정보를 활용하여 u-헬스케어 기반 질병예측 예방, 조기진단, 건강증진 기술개발 등을 포함하며, u-헬스케어 서비스 모델은 국민건강의 안전성과 효율성이 담보되고 산업활성화에 기여할 수 있는 u-헬스케어 서비스 모델 개발 등을 담고 있다. u-헬스케어 자유공모의 내용은 u-헬스케어의 기반이 되는 다양한 인프라, 기술, 서비스를 자유공모 형식으로 발굴함으로써 수용자 중심의 연구개발이 필요함을 제시하였다. u-Health 기술 내용중 세 번째로 u-헬스케어 TRM을 알아본다.

  • PDF

Improve the Support System for SMEs' Commercialization of Biohealth Industry: Focusing on TRL (바이오헬스 분야 사업화를 위한 지원체계 개선방안: TRL단계를 중심으로)

  • Jeon, Heesung;Rim, Yonghoon;Kang, Byungseok;Cho, Yun-Hee;Park, So-Jin
    • Journal of Digital Convergence
    • /
    • v.18 no.2
    • /
    • pp.83-93
    • /
    • 2020
  • As the importance of the biohealth industry has recently increased, innovative government support is required. However due to the limitation in the support framework, a complementary support system for commercialization is needed. This study examines the concept of TRL which the existing support being following, and investigates domestic support system and overseas support cases. It points out that the current TRL-based government support policy has limitations for the commercialization of the biohealth industry, which requires a lot of time and investment. The new concept of the support system reflecting the characteristics of the bio-industry and solving the problems of late R&D stage was proposed and connected with the policy direction. It is meaningful that the role as a guideline for overcoming the gap between research and industry for the commercialization of the biohealth.

Analysis on the Ripple and Investment Effect of Digital Bio-Healthcare Industry : Using Input-Output Tables 2019 (디지털바이오헬스케어(Digital Bio-Healthcare)산업의 파급효과 및 투자효과 분석 : 2019년 산업연관표를 중심으로)

  • Jang, Pilho;Kim, Yonghwan;Lee, Changwoon;Jun, Sungkyu;Jung, Myungjin
    • Journal of Internet Computing and Services
    • /
    • v.21 no.3
    • /
    • pp.71-81
    • /
    • 2020
  • The digital bio-healthcare industry is one of the three major fostering industries of the Korean Moon Jae-In government. The purpose of this study is to compare and analyze the ripple effect and investment effect in digital bio-healthcare industry. Analyzing the ripple effects of the digital bio-healthcare industry is very important to induce policies on industry and technology development. First, the research methods were reclassified into 33 industries in the standard industry classification and rewritten into 35 industry classification tables. Second, various trigger coefficients and ripple effects coefficients were rewritten by the analysis framework of the industrial association table. Third, we compared the ripple effects of related industries in the production, investment, value-added and jobs sectors of the digital bio-healthcare industry. Finally, in terms of investment effects, the effects of in-house and related industries were compared. The result of this study would be helpful in the establishment of industrial policy and technology development policy.

A Study on the Trend of Employment Effect and Employment Policy in the Digital Bio-healthcare Industry (디지털바이오헬스케어산업의 고용효과 추이 변화와 고용정책에 관한 연구)

  • Jang, Pil-Ho;Kim, Yong-Hwan
    • Journal of Convergence for Information Technology
    • /
    • v.11 no.1
    • /
    • pp.175-182
    • /
    • 2021
  • The purpose of this study is to establish the direction of industrial policy by comparing the employment inducement effect on the related industries of the digital bio-healthcare industry. The analysis data used the three-year input-output table measured by the Bank of Korea. First, the research method was rewritten into 7 major industries to compare statistical data by period. Second, the Bank of Korea's industry-related analysis methodology was utilized. Third, the weight was reflected and compared by employment, production, and investment sectors of the digital bio-healthcare industry. As a result of the analysis, first, the employment sector had a higher effect than the average of the entire industry, second, the production sector was low, and third, the investment sector required investment in the service sector. The conclusions drawn from the analysis showed that direct investment and continuous investment are required in the employment sector, the development of professional manpower is urgent, and direct investment and long-term investment are effective in the production sector.

Technology Convergence & Trend Analysis of Biohealth Industry in 5 Countries : Using patent co-classification analysis and text mining (5개국 바이오헬스 산업의 기술융합과 트렌드 분석 : 특허 동시분류분석과 텍스트마이닝을 활용하여)

  • Park, Soo-Hyun;Yun, Young-Mi;Kim, Ho-Yong;Kim, Jae-Soo
    • Journal of the Korea Convergence Society
    • /
    • v.12 no.4
    • /
    • pp.9-21
    • /
    • 2021
  • The study aims to identify convergence and trends in technology-based patent data for the biohealth sector in IP5 countries (KR, EP, JP, US, CN) and present the direction of development in that industry. We used patent co-classification analysis-based network analysis and TF-IDF-based text mining as the principal methodology to understand the current state of technology convergence. As a result, the technology convergence cluster in the biohealth industry was derived in three forms: (A) Medical device for treatment, (B) Medical data processing, and (C) Medical device for biometrics. Besides, as a result of trend analysis based on technology convergence results, it is analyzed that Korea is likely to dominate the market with patents with high commercial value in the future as it is derived as a market leader in (B) medical data processing. In particular, the field is expected to require technology convergence activation policies and R&D support strategies for the technology as the possibility of medical data utilization by domestic bio-health companies expands, along with the policy conversion of the "Data 3 Act" passed by the National Assembly in January 2019.

A Study on the Impact of Entrepreneurial Orientation and Self Efficacy on Entrepreneurial Intention - Focused on Bio-Healthcare Workers (기업가 지향성과 자기 효능감이 창업의도에 미치는 영향에 관한 연구 - 바이오·헬스케어 산업 종사자를 중심으로)

  • Jongsoo Hyun;Youngjun Kim
    • The Journal of the Convergence on Culture Technology
    • /
    • v.9 no.1
    • /
    • pp.627-633
    • /
    • 2023
  • This study sought to identify the effects of entrepreneurship orientation and self efficacy on entrepreneurial intentions among workers in the bio-healthcare industry in Korea. As interest in health increases in the age of aging, the bio-healthcare industry is attracting a lot of attention for start-ups as an industry that can create high added value, but there are also aspects that take a relatively long time to develop technology, require a lot of money, and have a relatively high probability of failure. In this study, we measured the level of entrepreneurship orientation and self efficacy of bio-healthcare industry workers and identified the degree of influence on entrepreneurial intentions. Studies have shown that innovativeness, progressiveness, and risk-taking among entrepreneurship orientations all have a significant impact on entrepreneurial intention. In addition, self efficacy has been shown to have a mediating effect on the relationship between innovativeness, progressiveness, risk-taking and entrepreneurial intention.

스마트 헬스케어 시장을 여는 열쇠, 모바일 의료기기

  • Lee, Bo-Gyeong
    • The Optical Journal
    • /
    • s.156
    • /
    • pp.41-51
    • /
    • 2015
  • 생명공학기술(BT)과 정보통신기술(IT)의 융합으로 모바일 의료기기가 최근 빠른 속도로 발전 하고 있다. 작년부터 시작된 헬스케어 웨어러블 디바이스의 열풍은 IT기업의 헬스케어 시장 진입을 촉진하고 있으며, 스마트폰의 보급으로 인해 의료기기의 활용도와 편리성이 비약적으로 향상되고 있다. 각각의 영역에서 발전하던 의료기기와 스마트기기는 이제 모바일 의료기기라는 하나의 시장에서 만난다. 의료진을 중심으로 개발되던 의료기기는 소비자의 관점에서 재조명되어 보다 유용한 기기로 탈바꿈하고 있다. 단순한 건강관리에서부터 중증질환의 치료에 이르기까지 모바일 의료기기가 제공하는 스마트 헬스케어 솔루션이 중요한 역할을 할 것으로 기대된다. 본 보고서는 최근의 바이오 기술과 헬스케어 스마트기기의 발달을 살펴보고, 모바일 의료기기가 가져올 스마트 헬스케어의 가능성과 극복해야 할 장애물에 대해 분석하였다. 특히 ICT 융합산업이 직면하게 되는 이종 산업의 속성 차이를 이해하는데 주안점을 두었다.

  • PDF

A Study on the Countermeasures Taken By the Korean Healthcare and Life Sciences Industry Regarding U.S. Import Refusals: Focus on the Analysis of FDA Violation Codes (한국 바이오헬스 산업의 미국 수입거부 대응 방안 연구 : FDA 위반코드 분석을 중심으로)

  • Yu-Han Lee;Hag-Min Kim
    • Korea Trade Review
    • /
    • v.48 no.3
    • /
    • pp.131-150
    • /
    • 2023
  • The purpose of this study was to find a countermeasure to the U.S. import refusals for the Korean healthcare and life sciences industry. To this end, an analysis of trends during the pandemic was conducted using the KITA Border Rejection Database, which includes information on items and types of import refusals. The reason for rejection was also analyzed according to the FDA violation codes. The degree of countermeasure for import refusals was identified by measuring the unit rejection rate (URR). The results of the analysis showed that the major U.S. import refusals for the Korean healthcare and life sciences industry had expanded from contact lenses to COVID-19 diagnostic kits and drugs after the pandemic broke out. The major reasons for import refusals were non-compliance with the Predicate Device and Drugs Act and non-approval by the FDA for products and facilities. On the other hand, the unit rejection rate (URR) of major items in the Korean healthcare and life sciences industry was measured higher than the industry average. The results therefore showed a low level of response to U.S. import refusals. The results of the analysis of reasons for import refusals by item according to FDA violation codes were as follows. First of all, the main violation for contact lenses and COVID-19 diagnostic kits corresponded to misbranding. This was often due to the fact that Korean companies did not provide the relevant notices and information required by the FDA. Many cases also failed to demonstrate a substantial equivalency compared to predicate devices already on the market. On the other hand, applications for new unapproved drugs were not accepted as they had yet to pass relevant regulations that would prove their safety and efficacy. In conclusion, import refusals for the Korean healthcare and life sciences industry were found to be closely related to technical barriers to trade (TBT).

A Review of the Genesis Process and Competitiveness Determinants of Overseas Bio-Industrial Cluster: Case Studies of the BioHealth Capital Region in the US, Cambridge in the UK, and Medicon Valley in Denmark and Sweden (국외 바이오산업 클러스터의 태동 과정과 경쟁력 결정요인에 관한 고찰: 미국 바이오헬스캐피털리전, 영국 케임브리지, 덴마크-스웨덴 메디콘밸리 사례)

  • Bong-Kyung, Jeon
    • Journal of the Economic Geographical Society of Korea
    • /
    • v.26 no.4
    • /
    • pp.375-390
    • /
    • 2023
  • This study examined the genesis process and competitiveness determinants of overseas bio-industrial clusters. The bio industry is a promising new industry that major countries around the world are paying attention to because it can be applied to various industries and can create high added value by combining artificial intelligence and information and communication technology. In addition, the importance of clusters is emphasized in that it requires connection and cooperation with various stakeholders. However, compared to this importance and interest, related research in Korea is somewhat insufficient. In particular, overseas case studies are also overly biased toward a few leading clusters, and tend to produce policies and development plans that do not correspond to domestic local conditions. To alleviate this problem, this study looked at the birth and growth process of the BioHealth Capital Region in the United States, Cambridge Cluster in the United Kingdom, and Medicon Valley in Denmark and Sweden. Through this, we aim to enrich related case studies that were lacking, identify the determinants of competitiveness of each cluster, and present implications for the creation and development of domestic bio industry clusters.

A Content Analysis on the Biomedical cluster: Focusing on the case of HongReung Digital Healthcare InnoTown (바이오·의료 클러스터 조성 및 활성화 방안에 대한 내용분석 연구: 홍릉 디지털 헬스케어 강소특구 사례를 중심으로)

  • Park, Kyuhong;Kim, Taehyung;Park, Yeonsoo;Song, Changhyeon
    • Journal of Digital Convergence
    • /
    • v.20 no.5
    • /
    • pp.761-776
    • /
    • 2022
  • For fostering the biomedical industry, the formation of a high-tech-based innovation cluster is continuously being promoted. Accordingly, studies dealing with domestic clusters are being conducted based on case studies on major overseas clusters, but they are limited to a single case. In this paper, content analysis was used based on the literature about innovation clusters and bio-medical industry to comprehensively summarize the factors to be considered for the creation and activation of bio-medical clusters. Subsequently, the factors derived through content analysis were applied to the case of the Hongreung Innotown. The requirements for the successful creation of the Hongreung Innotown, it is required to improve settlement conditions, prepare systems to create start-up culture, and revitalize translational research, attract investment, and cooperate and connect with local clusters.